Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features
about
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features
description
scientific article published on 13 November 2019
@en
name
Results of a Multicenter Phase ...... gy and/or Sarcomatoid Features
@en
type
label
Results of a Multicenter Phase ...... gy and/or Sarcomatoid Features
@en
prefLabel
Results of a Multicenter Phase ...... gy and/or Sarcomatoid Features
@en
P2093
P356
P1476
Results of a Multicenter Phase ...... gy and/or Sarcomatoid Features
@en
P2093
Abdallah Flaifel
Atish Choudhury
Bradley A McGregor
David A Braun
David F McDermott
Eliezer M Van Allen
Gordon J Freeman
John A Steinharter
Kathryn Gray
Kerry Kilbridge
P356
10.1200/JCO.19.01882
P577
2019-11-13T00:00:00Z